Basilius Sauter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Basilius Sauter has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Dennis Gillingham
Department of Chemistry, University of Basel, 4056 Basel, Switzerland
14 shared publications - Cedric J. Stress
Department of Chemistry, University of Basel, St. Johanns-Ring 19, CH-4056, Basel, Switzerland
2 shared publications Lukas A. Schneider
Department Chemie Universität Basel St. Johanns-Ring 19 4056 Basel Schweiz
2 shared publications- Pinwen Cai
University of Basel
2 shared publications Saule Zhanybekova
Department of Chemistry
2 shared publications- Timothy D. Sharpe
Biozentrum, University of Basel, Basel, Switzerland
2 shared publications
Latest Publications
- Open Access
- 29 April 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (5) , 1099-1106
Exploring the Potential of Homologous Recombination Protein PALB2 in Synthetic Lethal Combinations
Cells with defective homologous recombination (HR) are highly sensitive to poly(ADP-ribose) polymerase (PARP) inhibition. Current therapeutic approaches leverage this vulnerability by using PARP inhibitors in cells with genetically compromised HR. However, if HR factors in cancer cells could be inhibited or degraded pharmacologically, it might reveal other opportunities for synergistic combinations. In this study, we developed a model system that recapitulates PARP/HR synthetic lethality by integrating a small-molecule responsive zinc-finger degron into the HR factor Partner and Localizer of BRCA2 (PALB2). We further tested a series of peptide ligands for PALB2 based on its natural binding partners, which led to the discovery of a high affinity peptide that will support future work on PALB2 and HR. Together, our findings validate PALB2 as a promising drug target and provide the tools and starting points for developing molecules with therapeutic applications.
- 29 April 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (5) , 1099-1106
Open AccessExploring the Potential of Homologous Recombination Protein PALB2 in Synthetic Lethal Combinations
Cells with defective homologous recombination (HR) are highly sensitive to poly(ADP-ribose) polymerase (PARP) inhibition. Current therapeutic approaches leverage this vulnerability by using PARP inhibitors in cells with genetically compromised HR. However, if HR factors in cancer cells could be inhibited or degraded pharmacologically, it might reveal other opportunities for synergistic combinations. In this study, we developed a model system that recapitulates PARP/HR synthetic lethality by integrating a small-molecule responsive zinc-finger degron into the HR factor Partner and Localizer of BRCA2 (PALB2). We further tested a series of peptide ligands for PALB2 based on its natural binding partners, which led to the discovery of a high affinity peptide that will support future work on PALB2 and HR. Together, our findings validate PALB2 as a promising drug target and provide the tools and starting points for developing molecules with therapeutic applications.
- Open Access
- 31 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (18) , 7730-7738
A method to identify small molecule/protein pairs susceptible to protein ubiquitination by the CRBN E3 ligase
Using DNA-encoded libraries to identify protein binders is common, but finding molecules with functional activity remains challenging. We present here an encoded and pooled approach to discover catalysts for ubiquitin transfer.
- 31 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (18) , 7730-7738
Open AccessA method to identify small molecule/protein pairs susceptible to protein ubiquitination by the CRBN E3 ligase
Using DNA-encoded libraries to identify protein binders is common, but finding molecules with functional activity remains challenging. We present here an encoded and pooled approach to discover catalysts for ubiquitin transfer.
- Open Access
- 26 March 2025
- Published by Swiss Chemical Society in Chimia
- Vol. 79 (3) , 158-161
Challenges and Opportunities in DNA Encoded Library Screens
In our lab we have been developing techniques that attempt to capture or amplify signals in pooled compound mixtures for several years. DNA encoded libraries (DELs) are the most widely used pooled mixtures in early drug discovery. DELs are massive collections of small molecules, where each individual molecule is covalently linked to a unique DNA strand that can serve as an identification tag by sequencing. The industry standard for selecting DELs is affinity enrichment, which inherently can only search for direct binding. We outline here two of the ways that we are attempting to extend the potential of DEL screens into new areas.
- 26 March 2025
- Published by Swiss Chemical Society in Chimia
- Vol. 79 (3) , 158-161
Open AccessChallenges and Opportunities in DNA Encoded Library Screens
In our lab we have been developing techniques that attempt to capture or amplify signals in pooled compound mixtures for several years. DNA encoded libraries (DELs) are the most widely used pooled mixtures in early drug discovery. DELs are massive collections of small molecules, where each individual molecule is covalently linked to a unique DNA strand that can serve as an identification tag by sequencing. The industry standard for selecting DELs is affinity enrichment, which inherently can only search for direct binding. We outline here two of the ways that we are attempting to extend the potential of DEL screens into new areas.
- Open Access
- 17 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A method to identify small molecule/protein pairs susceptible to protein ubiquitination by the CRBN E3 ligase
Although using DNA-encoded libraries (DELs) to find small molecule binders of target proteins is well-established, identifying molecules with functions beyond binding remains challenging in pooled screens. Here, we develop an approach for multiplexing functional screens that simultaneously evaluates encoded small molecules and encoded collections of protein targets in functional selections. We focus on ubiquitin (Ub) transfer with the cereblon-bound CRL4 E3 ligase because of its proven versatility in drug discovery. The functional selections recover small molecule/G-hairpin loop pairs based on their ability to promote Ub-transfer onto the G-hairpin loop. As Ub-transfer is the first step in tagging proteins for proteasomal destruction, finding small molecules capable of selectively reprogramming it is a significant challenge in contemporary drug development. Our work lays the foundation for functional DEL selections that match small molecule Ub-transfer catalysts with their optimal protein substrates.
- 17 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA method to identify small molecule/protein pairs susceptible to protein ubiquitination by the CRBN E3 ligase
Although using DNA-encoded libraries (DELs) to find small molecule binders of target proteins is well-established, identifying molecules with functions beyond binding remains challenging in pooled screens. Here, we develop an approach for multiplexing functional screens that simultaneously evaluates encoded small molecules and encoded collections of protein targets in functional selections. We focus on ubiquitin (Ub) transfer with the cereblon-bound CRL4 E3 ligase because of its proven versatility in drug discovery. The functional selections recover small molecule/G-hairpin loop pairs based on their ability to promote Ub-transfer onto the G-hairpin loop. As Ub-transfer is the first step in tagging proteins for proteasomal destruction, finding small molecules capable of selectively reprogramming it is a significant challenge in contemporary drug development. Our work lays the foundation for functional DEL selections that match small molecule Ub-transfer catalysts with their optimal protein substrates.
- 1 January 2024
- Published by Georg Thieme Verlag KG
3.2.3.1 Macrocyclic DELs
Although biologically active macrocycles are commonly found in natural products, these complex structures have not been utilized as often in man-made drugs. DNA-encoded libraries offer the opportunity to create large libraries of macrocycles for testing, without the need to invest large quantities of time and resources into the chemical synthesis of individual compounds. This chapter provides an overview of the major strategies developed by DEL practitioners in creating macrocycle libraries. An introduction to the field is followed by sections focused on specific DEL-synthesis campaigns where each individual strategy was used.
- 1 January 2024
- Published by Georg Thieme Verlag KG
3.2.3.1 Macrocyclic DELs
Although biologically active macrocycles are commonly found in natural products, these complex structures have not been utilized as often in man-made drugs. DNA-encoded libraries offer the opportunity to create large libraries of macrocycles for testing, without the need to invest large quantities of time and resources into the chemical synthesis of individual compounds. This chapter provides an overview of the major strategies developed by DEL practitioners in creating macrocycle libraries. An introduction to the field is followed by sections focused on specific DEL-synthesis campaigns where each individual strategy was used.
- Open Access
- 13 September 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (38) , 20874-20882
Recording Binding Information Directly into DNA-Encoded Libraries Using Terminal Deoxynucleotidyl Transferase
Terminal deoxynucleotidyl transferase (TdT) is an unusual DNA polymerase that adds untemplated dNTPs to 3'-ends of DNA. If a target protein is expressed as a TdT fusion and incubated with a DNA-encoded library (DEL) in the presence of dATP, the binders of the target induce proximity between TdT and the DNA, promoting the synthesis of a poly-adenine (polyA) tail. The polyA tail length is proportional to the binding affinity, effectively serving as a stable molecular record of binding events. The polyA tail is also a convenient handle to enrich binders with magnetic poly(dT)25 beads before sequencing. In a benchmarking system, we show that ligands spanning nanomolar to double-digit micromolar binding can be cleanly identified by TdT extension, whereas only the tightest binding ligands are identified by classical affinity selection. The method is simple to implement and can function on any DEL that bears a free 3'-end.
- 13 September 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (38) , 20874-20882
Open AccessRecording Binding Information Directly into DNA-Encoded Libraries Using Terminal Deoxynucleotidyl Transferase
Terminal deoxynucleotidyl transferase (TdT) is an unusual DNA polymerase that adds untemplated dNTPs to 3'-ends of DNA. If a target protein is expressed as a TdT fusion and incubated with a DNA-encoded library (DEL) in the presence of dATP, the binders of the target induce proximity between TdT and the DNA, promoting the synthesis of a poly-adenine (polyA) tail. The polyA tail length is proportional to the binding affinity, effectively serving as a stable molecular record of binding events. The polyA tail is also a convenient handle to enrich binders with magnetic poly(dT)25 beads before sequencing. In a benchmarking system, we show that ligands spanning nanomolar to double-digit micromolar binding can be cleanly identified by TdT extension, whereas only the tightest binding ligands are identified by classical affinity selection. The method is simple to implement and can function on any DEL that bears a free 3'-end.
- Open Access
- 1 December 2021
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 52, 116508
An assessment of the mutational load caused by various reactions used in DNA encoded libraries
- 1 December 2021
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 52, 116508
Open AccessAn assessment of the mutational load caused by various reactions used in DNA encoded libraries
- Open Access
- 30 September 2020
- Published by Swiss Chemical Society in Chimia
- Vol. 74 (9) , 693-698
DNA Damaging Agents in Chemical Biology and Cancer
Despite their toxicity, DNA alkylating drugs remain a cornerstone of anticancer therapy. The classical thinking was that rapidly dividing tumour cells left more of its DNA in an exposed single-stranded state, making these rapidly dividing cells more susceptible to alkylating drugs. As our understanding of DNA repair pathways has matured it is becoming clear that compromised DNA repair – a hallmark of cancer – plays a role as well in defining the therapeutic window of these toxic drugs. Hence, although new alkylating motifs are unlikely to progress through the clinic, the legacy of these medicines is that we now understand the therapeutic potential of targeting DNA damage repair pathways. Here we look at the history of alkylating agents as anticancer drugs, while also summarizing the different mechanistic approaches to covalent DNA modification. We also provide several case studies on how insights into compromised DNA repair pathways are paving the way for potent and less toxic targeted medicines against the DNA damage response.
- 30 September 2020
- Published by Swiss Chemical Society in Chimia
- Vol. 74 (9) , 693-698
Open AccessDNA Damaging Agents in Chemical Biology and Cancer
Despite their toxicity, DNA alkylating drugs remain a cornerstone of anticancer therapy. The classical thinking was that rapidly dividing tumour cells left more of its DNA in an exposed single-stranded state, making these rapidly dividing cells more susceptible to alkylating drugs. As our understanding of DNA repair pathways has matured it is becoming clear that compromised DNA repair – a hallmark of cancer – plays a role as well in defining the therapeutic window of these toxic drugs. Hence, although new alkylating motifs are unlikely to progress through the clinic, the legacy of these medicines is that we now understand the therapeutic potential of targeting DNA damage repair pathways. Here we look at the history of alkylating agents as anticancer drugs, while also summarizing the different mechanistic approaches to covalent DNA modification. We also provide several case studies on how insights into compromised DNA repair pathways are paving the way for potent and less toxic targeted medicines against the DNA damage response.
- Open Access
- 2 April 2019
- Published by Wiley in Angewandte Chemie
- Vol. 131 (28) , 9671-9675
Eine DNA‐kodierte Molekülbibliothek mit Elementen natürlicher Makrocyclen
Wir zeigen die Synthese einer DNA‐kodierten Makrocyclenbibliothek (DKMB) über sieben Schritte auf DNA. Diese Bibliothek wurde, inspiriert von Polyketid‐ und gemischten Peptid‐Polyketid‐Naturstoffen, mit stark variierender Grundstruktur geplant. Die hohe Vielfalt wurde mit selbst synthetisierten Bausteinen erreicht, deren Herstellung allerdings arbeitsintensiv ist. Diese Studie zeigt die Wichtigkeit eines durchdachten Retrosynthesedesigns von DNA‐kodierten Bibliotheken und offenbart Herausforderungen, für die neue, DNA‐kompatible Synthesemethoden benötigt werden.
- 2 April 2019
- Published by Wiley in Angewandte Chemie
- Vol. 131 (28) , 9671-9675
Open AccessEine DNA‐kodierte Molekülbibliothek mit Elementen natürlicher Makrocyclen
Wir zeigen die Synthese einer DNA‐kodierten Makrocyclenbibliothek (DKMB) über sieben Schritte auf DNA. Diese Bibliothek wurde, inspiriert von Polyketid‐ und gemischten Peptid‐Polyketid‐Naturstoffen, mit stark variierender Grundstruktur geplant. Die hohe Vielfalt wurde mit selbst synthetisierten Bausteinen erreicht, deren Herstellung allerdings arbeitsintensiv ist. Diese Studie zeigt die Wichtigkeit eines durchdachten Retrosynthesedesigns von DNA‐kodierten Bibliotheken und offenbart Herausforderungen, für die neue, DNA‐kompatible Synthesemethoden benötigt werden.
- Open Access
- 2 April 2019
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (28) , 9570-9574
A DNA‐Encoded Chemical Library Incorporating Elements of Natural Macrocycles
Here we show a seven‐step chemical synthesis of a DNA‐encoded macrocycle library (DEML) on DNA. Inspired by polyketide and mixed peptide‐polyketide natural products, the library was designed to incorporate rich backbone diversity. Achieving this diversity, however, comes at the cost of the custom synthesis of bifunctional building block libraries. This study outlines the importance of careful retrosynthetic design in DNA‐encoded libraries, while revealing areas where new DNA synthetic methods are needed.
- 2 April 2019
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (28) , 9570-9574
Open AccessA DNA‐Encoded Chemical Library Incorporating Elements of Natural Macrocycles
Here we show a seven‐step chemical synthesis of a DNA‐encoded macrocycle library (DEML) on DNA. Inspired by polyketide and mixed peptide‐polyketide natural products, the library was designed to incorporate rich backbone diversity. Achieving this diversity, however, comes at the cost of the custom synthesis of bifunctional building block libraries. This study outlines the importance of careful retrosynthetic design in DNA‐encoded libraries, while revealing areas where new DNA synthetic methods are needed.